These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11145040)

  • 1. Differential expression of matrix metalloproteinases in labial salivary glands of patients with primary Sjögren's syndrome.
    Pérez P; Goicovich E; Alliende C; Aguilera S; Leyton C; Molina C; Pinto R; Romo R; Martinez B; González MJ
    Arthritis Rheum; 2000 Dec; 43(12):2807-17. PubMed ID: 11145040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased acinar damage of salivary glands of patients with Sjögren's syndrome is paralleled by simultaneous imbalance of matrix metalloproteinase 3/tissue inhibitor of metalloproteinases 1 and matrix metalloproteinase 9/tissue inhibitor of metalloproteinases 1 ratios.
    Pérez P; Kwon YJ; Alliende C; Leyton L; Aguilera S; Molina C; Labra C; Julio M; Leyton C; González MJ
    Arthritis Rheum; 2005 Sep; 52(9):2751-60. PubMed ID: 16142742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced degradation of proteins of the basal lamina and stroma by matrix metalloproteinases from the salivary glands of Sjögren's syndrome patients: correlation with reduced structural integrity of acini and ducts.
    Goicovich E; Molina C; Pérez P; Aguilera S; Fernández J; Olea N; Alliende C; Leyton C; Romo R; Leyton L; González MJ
    Arthritis Rheum; 2003 Sep; 48(9):2573-84. PubMed ID: 13130477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of cytokines in the destruction of acinar structure in Sjögren's syndrome salivary glands.
    Azuma M; Motegi K; Aota K; Hayashi Y; Sato M
    Lab Invest; 1997 Sep; 77(3):269-80. PubMed ID: 9314950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Abnormal interferon-inducible protein-10 expression in the labial glands of patients with Sjogren's syndrome].
    Zhou W; Dong Y; Zhao Y; Tang FL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Oct; 25(5):603-7. PubMed ID: 14650168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinase (MMP)-9 type IV collagenase/gelatinase implicated in the pathogenesis of Sjögren's syndrome.
    Konttinen YT; Halinen S; Hanemaaijer R; Sorsa T; Hietanen J; Ceponis A; Xu JW; Manthorpe R; Whittington J; Larsson A; Salo T; Kjeldsen L; Stenman UH; Eisen AZ
    Matrix Biol; 1998 Oct; 17(5):335-47. PubMed ID: 9822200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of matrix metalloproteinases and their inhibitors in medulloblastomas and their prognostic relevance.
    Ozen O; Krebs B; Hemmerlein B; Pekrun A; Kretzschmar H; Herms J
    Clin Cancer Res; 2004 Jul; 10(14):4746-53. PubMed ID: 15269148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of MMP-2 (gelatinase A) and MMP-9 (gelatinase B) by interferon-gamma in a human salivary gland cell line.
    Wu AJ; Lafrenie RM; Park C; Apinhasmit W; Chen ZJ; Birkedal-Hansen H; Yamada KM; Stetler-Stevenson WG; Baum BJ
    J Cell Physiol; 1997 May; 171(2):117-24. PubMed ID: 9130458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjögren's syndrome.
    Lavie F; Miceli-Richard C; Quillard J; Roux S; Leclerc P; Mariette X
    J Pathol; 2004 Apr; 202(4):496-502. PubMed ID: 15095277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excessive synthesis of matrix metalloproteinases in exocrine tissues of NOD mouse models for Sjögren's syndrome.
    Yamachika S; Nanni JM; Nguyen KH; Garces L; Lowry JM; Robinson CP; Brayer J; Oxford GE; da Silveira A; Kerr M; Peck AB; Humphreys-Beher MG
    J Rheumatol; 1998 Dec; 25(12):2371-80. PubMed ID: 9858432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase in the ratio of matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 in saliva from patients with primary Sjögren's syndrome.
    Asatsuma M; Ito S; Watanabe M; Takeishi H; Nomura S; Wada Y; Nakano M; Gejyo F; Igarashi A
    Clin Chim Acta; 2004 Jul; 345(1-2):99-104. PubMed ID: 15193983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Segment-specific but pathologic laminin isoform profiles in human labial salivary glands of patients with Sjogren's syndrome.
    Laine M; Virtanen I; Salo T; Konttinen YT
    Arthritis Rheum; 2004 Dec; 50(12):3968-73. PubMed ID: 15593200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
    Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinases in mild and severe temporomandibular joint internal derangement synovial fluid.
    Srinivas R; Sorsa T; Tjäderhane L; Niemi E; Raustia A; Pernu H; Teronen O; Salo T
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 May; 91(5):517-25. PubMed ID: 11346728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis.
    Kanyama M; Kuboki T; Kojima S; Fujisawa T; Hattori T; Takigawa M; Yamashita A
    J Orofac Pain; 2000; 14(1):20-30. PubMed ID: 11203734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal expression of matrix metalloproteinases in human ANCA-associated glomerulonephritis.
    Sanders JS; van Goor H; Hanemaaijer R; Kallenberg CG; Stegeman CA
    Nephrol Dial Transplant; 2004 Jun; 19(6):1412-9. PubMed ID: 15034162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of tumor necrosis factor alpha-induced matrix metalloproteinase 9 production by the introduction of a super-repressor form of inhibitor of nuclear factor kappaBalpha complementary DNA into immortalized human salivary gland acinar cells. Prevention of the destruction of the acinar structure in Sjögren's syndrome salivary glands.
    Azuma M; Aota K; Tamatani T; Motegi K; Yamashita T; Harada K; Hayashi Y; Sato M
    Arthritis Rheum; 2000 Aug; 43(8):1756-67. PubMed ID: 10943866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gelatinase expression and activity in the synovium and skin of patients with erosive psoriatic arthritis.
    Hitchon CA; Danning CL; Illei GG; El-Gabalawy HS; Boumpas DT
    J Rheumatol; 2002 Jan; 29(1):107-17. PubMed ID: 11824946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of matrix metalloproteinases in the microenvironment of spontaneous and experimental melanoma metastases reflects the requirements for tumor formation.
    Hofmann UB; Eggert AA; Blass K; Bröcker EB; Becker JC
    Cancer Res; 2003 Dec; 63(23):8221-5. PubMed ID: 14678978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis and cell proliferation: the paradox of salivary glands in Sjögren's disease.
    Herrera-Esparza R; Bollain-y-Goytia J; Ruvalcaba C; Ruvalcaba M; Pacheco-Tovar D; Avalos-Díaz E
    Acta Reumatol Port; 2008; 33(3):299-303. PubMed ID: 18846009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.